Acciones Callitas Health Inc. Canadian Securities Exchange
Acciones
LILY
CA13125C1068
Biotecnología e investigación médica
Ventas 2018 | 0,75 1,02 0,69 | Ventas 2019 | 0,71 0,97 0,65 | Capitalización | 3,53 M 4,82 M 3,25 M |
---|---|---|---|---|---|
Resultado Neto 2018 | -5 M -6,83 M -4,61 M | Resultado Neto 2019 | -1 M -1,37 M -922 mil | VE / Ventas 2018 | 4.852.616 x |
Deuda neta 2018 | 319 mil 436 mil 294 mil | Deuda neta 2019 | 848 mil 1,16 M 781 mil | VE / Ventas 2019 | 6.168.166 x |
P/E ratio 2018 |
-0,6
x | P/E ratio 2019 |
-1,97
x | Empleados | - |
Rendimiento 2018 * |
-
| Rendimiento 2019 |
-
| Flotante | 72,04 % |
Directores | Puesto | Edad | Desde |
---|---|---|---|
Chief Executive Officer | - | 03/01/18 | |
Robert Payment
DFI | Director of Finance/CFO | 42 | - |
Brian Keane
BRD | Director/Board Member | 47 | - |
Administradores | Puesto | Edad | Desde |
---|---|---|---|
Donald Skeith
BRD | Director/Board Member | 69 | 01/12/14 |
William Rodgers
BRD | Director/Board Member | - | - |
Brian Keane
BRD | Director/Board Member | 47 | - |
Varia. 1 de ene. | Capi. | |
---|---|---|
+42,66 % | 54,04 mil M | |
+43,57 % | 41,96 mil M | |
-1,42 % | 41,92 mil M | |
-7,59 % | 28,35 mil M | |
+11,64 % | 26,35 mil M | |
-22,01 % | 19 mil M | |
+7,80 % | 13 mil M | |
+28,87 % | 12,28 mil M | |
+25,84 % | 12,19 mil M |